A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily

PHASE3CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

September 2, 2021

Primary Completion Date

February 11, 2022

Study Completion Date

February 11, 2022

Conditions
Presbyopia
Interventions
DRUG

Pilocarpine HCl

Pilocarpine HCl ophthalmic solution 1.25% ocular drops.

DRUG

Vehicle

Oxymetazoline HCl and pilocarpine HCl placebo ocular drops.

Trial Locations (23)

34429

Nature Coast Clinical Research - Crystal River /ID# 231298, Crystal River

37167

Advancing Vision Research /ID# 231244, Smyrna

78229

Eye associates /ID# 231262, San Antonio

90301

United Medical Research Institute /ID# 233982, Inglewood

93309-0637

Empire Eye and Laser /ID# 231433, Bakersfield

91204-2500

Global Research Management /ID# 231300, Glendale

91345-1200

North Valley Eye Medical Group, Inc. /ID# 231270, Mission Hills

92663-3637

The Eye Research Foundation /ID# 231274, Newport Beach

95670-2968

Martel Eye Medical Group /ID# 231332, Rancho Cordova

33484-6540

Bruce Segal, MD /ID# 231413, Delray Beach

30260-4180

Clayton Eye Clinical Research, LLC /ID# 231243, Morrow

60046-8563

Jacksoneye, SC /ID# 231374, Lake Villa

46260-5381

Price Vision Group /ID# 231261, Indianapolis

66762-2620

Kannarr Eye Care /ID# 231363, Pittsburg

41017-3415

Cincinnati Eye Institute- Edgewood /ID# 231356, Edgewood

40206-1738

The Eye Care Institute /ID# 231275, Louisville

14618-2616

Rochester Ophthalmological Group PC /ID# 231371, Rochester

38104-2211

Southern College of Optometry /ID# 231325, Memphis

38119-5745

Total Eye Care, PA /ID# 231245, Memphis

78613-7651

Hill Country Eye Center /ID# 231293, Cedar Park

79902-1444

The Cataract & Glaucoma Center /ID# 231292, El Paso

84020-7133

Hoopes, Durrie, Rivera Research /ID# 231273, Draper

84403-2200

Country Hills Eye Center /ID# 231414, Ogden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY